HOME - Companies - News
15 March 2023

Henry Schein highlights the use of AI, other digital solutions at IDS 2023

Mary Guiden

Henry Schein, Inc. featured its comprehensive solutions and provided its perspective on the future of dentistry at the 2023 International Dental Show (IDS) in Cologne, Germany this week.

To kick off the show, Henry Schein presented “Integrated Digital Dentistry: The Future of Data, Devices, and Software,” a media briefing March 14. 

In opening remarks, Gerard Meuchner, vice president and chief global communications officer, said the audience was aware of the “explosion of new technology” occurring at the present time, including artificial intelligence and 3D printing.

“That promises to accelerate the delivery of health care in the field of dentistry,” he said.  

Meuchner shared a clip asking ChatGPT how it would describe the future of dentistry. The AI chatbot replied with: 

In the future, dentistry has undergone a major transformation. Advances in technology have made it possible to detect and prevent oral health problems before they become serious. This has resulted in a shift from the traditional approach of fixing problems after they arise, to a proactive and preventive approach that helps maintain optimal oral health. One of the most significant changes in the field of dentistry is the widespread use of artificial intelligence. AI-powered tools and devices have revolutionized the way dentists diagnose and treat oral health problems. For example, AI-powered x-ray machines can quickly and accurately identify potential issues, such as cavities or gum disease, and provide detailed images to help dentists make informed decisions about treatment. Another major change is the use of 3D printing technology. Dentists can now use 3D printers to create custom-fitted dental implants, crowns and other prosthetics in a matter of hours. This has greatly reduced the waiting time for patients and improved the accuracy and comfort of the products. The use of robotics in dentistry is also on the rise. Robotic systems can assist dentists in complex procedures, such as extractions and implant placement, reducing the risk of human error and improving the precision and speed of the procedure. Virtual reality technology is also being integrated into dentistry, allowing dentists to provide a more immersive and interactive experience for patients. Patients can tour virtual representations of their mouths and see what treatments will look like before they are actually performed. Despite these advancements, the human touch is still very much a part of dentistry. Dentists continue to play a critical role in guiding patients through their oral health journeys, providing personalized care and support. In conclusion, the future of dentistry is incredibly promising, with technology playing a vital role in improving the quality of care and the overall experience for patients. The field will continue to evolve and adapt to meet the changing needs of patients and provide the best possible oral health outcomes.    

Stanley M. Bergman, chairman of the board and CEO opened the briefing with a presentation about the company’s view of the future of dentistry, including technological advances such as artificial intelligence. 

Watch his presentation on the Henry Schein site: https://henryschein.wistia.com/medias/v141yw66ev

According to a press release, Bergman was joined by Dr. René Willi, CEO of the company’s Global Oral Reconstruction Group, who offered commentary on available and future technology solutions. In addition, Andrea Albertini, CEO of Henry Schein’s International Distribution Group, provided insights about how these solutions can be integrated into the dental workflow to help deliver an exceptional customer experience, high-quality patient care, and increased efficiency. 

Dr. Irena Sailer, professor and head of the Division of Fixed Prosthodontics and Biomaterials at the University of Geneva, presented insights on “Reconstructive Dentistry - Application of Technology Today and Tomorrow.”

The company featured a comprehensive display of its expansive portfolio of products and solutions in the exhibition hall, according to the press release. The showcased products included:

  • innovative orthodontic treatment solutions from Henry Schein Orthodontics, and orthodontic supplies from Ortho Technology,
  • dental handpieces from B.A. International,
  • solutions to help maintain and repair dental handpieces from Handpiece Headquarters,
  • premier dental surgical supplies from ACE Surgical,
  • minimally invasive whitening and restorative solutions from White Dental Beauty,
  • a broad range of Henry Schein Brand consumable products, and
  • endodontic solutions from EdgeEndo.

During IDS, Professor Gianluca Gambarini, head of endodontic and restorative at the University of Rome, La Sapienza, Dental School, and director of the master’s degree program of endodontics in Sapienza discussed the latest innovative endodontic instruments from EdgeEndo at the Henry Schein stand under the motto “Improving Efficacy & Simplicity of Canal Preparation with New EdgeEndo Martensitic Files.” 

Gambarini also works in Rome with a private practice specializing in endodontics.

Visit www.henryschein.com/IDS2023 to access translated versions of the press release, speaker photos and bios. An on-demand version of all presentations will also be available on the website following the conclusion of the program.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.6 billion in 2022 and have grown at a compound annual rate of approximately 12.1 percent since Henry Schein became a public company in 1995.

Related articles

Authors say chatbot may supplement existing learning programs

Periodontal disease is a chronic inflammatory disease that affects the periodontium and is classified into gingivitis and periodontitis with reversible and irreversible tissue damage.

UCSF School of Dentistry has received a $4 million National Institutes of Health (NIH) grant to build clinical research capabilities within oral health. The grant will train School of Dentistry...

Oral cancer (OC) is one of the most common forms of head and neck cancer and continues to have the lowest survival rates worldwide, despite advances in research and therapy. The prognosis of OC has...

The new software aims to streamline the guided surgery workflow and provide dentists with a comprehensive guided surgery solution.

Read more

USA     22 February 2024 - 24 February 2024

2024 Chicago Midwinter Meeting

Early-bird rates available through Nov. 30

The 2024 Midwinter Meeting provides exceptional continuing education featuring top dental speakers, an expansive Exhibit Hall with the best vendors in the country and opportunities to meet old and...

USA     22 February 2024 - 23 February 2024

Save the date: A new era for prosthodontics Feb. 2024

95th Annual Meeting of the American Prosthodontic Society

APS Members and colleagues will enjoy relevant education in advanced prosthodontics and implantology, interdisciplinary instruction led by world-renowned experts, and networking and social events...

The U.S. Food and Drug Administration (FDA) has approved Dr. Jonathan An from the UW Department of Oral Health Sciences to lead the first-ever study to evaluate rapamycin in older adults with...

The American Association for Anatomy (AAA) announced its 2024 award recipients, recognizing outstanding contributions to the field. Two UCSF School of Dentistry professors were among the respected...

The National Mobile & Teledentistry Conference (NMTC), the only educational conference geared towards virtual and mobile dental care, is excited to announce our 5-year anniversary at our upcoming...



Most popular